Filing Flows › Precision Biosciences (DTIL) › Q3 FY26 › vs Q3 FY25
Precision Biosciences (DTIL) Q3 FY26 vs Q3 FY25 (year over year)
Precision Biosciences's revenue rose $10.8M (374×) from $29K in Q3 FY25 to $10.8M in Q3 FY26.
Precision Biosciences, Q3 FY26: revenue $10.8M (374× year over year), operating margin -83.7%, net loss $18.4M, operating cash flow −$11.9M. The chart draws each line against Q3 FY25, the increases inside each band.
Every line
| Line | Q3 FY26 | Q3 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $10.8M | $29K | $10.8M | 374× |
| Net loss | $18.4M | $20.6M | −$2.1M | -10% |
| Costs & expenses | $29.3M | $22.1M | $7.1M | +32% |
| Operating costs | $19.9M | $22.1M | −$2.2M | -10% |
| Interest & other, net | $9.4M | −$1.5M | $10.9M | — |
| Research & development | $13.1M | $13.6M | −$478K | -4% |
| General & admin | $6.8M | $8.6M | −$1.8M | -20% |
| Operating cash sources | $18.4M | $20.6M | −$2.1M | -10% |
| Depreciation & amortization | $299K | $395K | −$96K | -24% |
| Share-based compensation | $1.5M | $2.8M | −$1.3M | -45% |
| Working capital & other | $4.7M | −$1.7M | $6.4M | — |
| Cash used in operations | $11.9M | $19.1M | −$7.1M | -37% |
| Net loss absorbed | $18.4M | $20.6M | −$2.1M | -10% |
Questions
How much did Precision Biosciences's revenue grow year over year in Q3 FY26?
Precision Biosciences's revenue rose $10.8M (374×) from $29K in Q3 FY25 to $10.8M in Q3 FY26.